CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
25 hedge funds and large institutions have $38.3M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
3
Increased
4
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$106K |
| 2 |
Renaissance Technologies
New York
|
+$98.1K |
| 3 |
LPL Financial
San Diego,
California
|
+$29K |
| 4 |
JPMorgan Chase & Co
New York
|
+$20.1K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.46K |
Top Sellers
| 1 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$1.37M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
-$1.13M |
| 3 |
DMK
David M. Knott
|
-$105K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$54K |
| 5 |
Morgan Stanley
New York
|
-$19.4K |
